⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMTX News
Immatics N.V. Ordinary Shares
Immatics Announces Full Year 2025 Financial Results and Business Update
globenewswire.com
IMTX
Ionic Mineral Technologies Secures Major SITLA Land Expansion at Silicon Ridge, Confirms Large-Scale Mineral System Continuity
businesswire.com
IMTX
Elevar Therapeutics Names Dong-Gun Kim CEO as It Focuses on Post-NDA Commercialization Strategy
globenewswire.com
IMTX
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
MGNX
IMTX
LLY
PFE
Insights Into the Booming Peptide Cancer Vaccines Market 2025-2031: Key Trends & Opportunities in Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, and Other Applications - ResearchAndMarkets.com
businesswire.com
IMTX
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
globenewswire.com
IMTX
Immatics Announces $125 Million Underwritten Offering
globenewswire.com
IMTX
Immatics Announces Third Quarter 2025 Financial Results and Business Update
globenewswire.com
IMTX
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
globenewswire.com
IMTX